P1133 COMPARISON OF 24 AND 48 WEEKS OF TREATMENT WITH FALDAPREVIR AND PEGYLATED INTERFERON/RIBAVIRIN IN PATIENTS WITH DETECTABLE BUT NOT QUANTIFIABLE HCV RNA AT WEEK 4
| Autor: | Mallolas, J., Battegay, M., Guardiola, J.M., Rockstroh, J.K., Soriano, V., Leen, C., Núñez, M., Valdez Madruga, J., Rauch, A., Stern, J.O., Quinson, A.-M., Vinisko, R., Manero, M., Dieterich, D. |
|---|---|
| Zdroj: | In Journal of Hepatology April 2014 60(1) Supplement:S459-S459 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect